Understanding GS-441524: Pain Levels in Cats during FIP Treatment
Feline Infectious Peritonitis, a.k.a. FIP is a viral infection that afflicts an estimated 1~2% of the global feline population annually. FIP is fatal if untreated, with an estimated mortality rate of ~96%.
A medical breakthrough was made when U.S. researchers discovered the effectiveness of using the antiviral drug GS-441524 to treat FIP. In the past 4 years, increasing number of doctors are using GS-441524 to treat FIP, and its use has spread globally, saving countless cats.
At BASMI FIP™, we are working tirelessly to bring this effective FIP treatment to cat owners and veterinary professionals across Asia, so that they may use it to save the lives of their cats.
TREATMENT OPTION 1 :
TREATMENT OPTION 2 :
FIP Treatment Knowledge
BASMI FIP™ was found in 2019 with the mission to save cats from Feline Infectious Peritonitis (FIP) related death throughout Southeast Asia. Building upon the groundbreaking clinical study by Dr. Pedersen in the United States, we have helped over 18,000 cat owners and doctors successfully treat Feline Infectious Peritonitis. A once deadly disease, today we are able to heal 93.7% of the cats that undertake our FIP treatment.